BRIEF-Timber Pharmaceuticals Says Prior To Filing Of Chapter 11 Case, Debtors Entered Into A "Stalking Horse" Asset Purchase Agreement

Reuters2023-11-18

Nov 17 (Reuters) - Timber Pharmaceuticals Inc :

* TIMBER PHARMACEUTICALS INC: PRIOR TO FILING OF CHAPTER 11 CASE, DEBTORS ENTERED INTO A "STALKING HORSE" ASSET PURCHASE AGREEMENT

* TIMBER PHARMACEUTICALS: AGREEMENT WAS TO SELL SUBSTANTIALLY ALL OF ASSETS OF CO, UNITS, INCLUDING TMB-001, FOR OF $14.35 MILLION PLUS CERTAIN LIABILITIES

* TIMBER PHARMACEUTICALS INC: COMPANY AND PARENT HAVE ALSO AGREED TO ENTER INTO A DEBTOR-IN-POSSESSION CREDIT FACILITY

Further company coverage:

((reuters.briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2384395029?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-11-18 06:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2384395029","market":"us","top_or_hot":-1,"title":"BRIEF-Timber Pharmaceuticals Says Prior To Filing Of Chapter 11 Case, Debtors Entered Into A \"Stalking Horse\" Asset Purchase Agreement","media":"Reuters","content":"<html><body><p>Nov 17 (Reuters) - <a href=\"https://laohu8.com/S/TMBR\">Timber Pharmaceuticals</a> Inc   :</p><p>   * TIMBER PHARMACEUTICALS INC: PRIOR TO FILING OF CHAPTER 11 CASE, DEBTORS ENTERED INTO A \"STALKING HORSE\" ASSET PURCHASE AGREEMENT</p><p>   * TIMBER PHARMACEUTICALS: AGREEMENT WAS TO SELL SUBSTANTIALLY ALL OF ASSETS OF CO, UNITS, INCLUDING TMB-001, FOR OF $14.35 MILLION PLUS CERTAIN LIABILITIES</p><p>   * TIMBER PHARMACEUTICALS INC: COMPANY AND PARENT HAVE ALSO AGREED TO ENTER INTO A DEBTOR-IN-POSSESSION CREDIT FACILITY</p><p>Further company coverage:   </p><p> ((reuters.briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Timber Pharmaceuticals Says Prior To Filing Of Chapter 11 Case, Debtors Entered Into A \"Stalking Horse\" Asset Purchase Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Timber Pharmaceuticals Says Prior To Filing Of Chapter 11 Case, Debtors Entered Into A \"Stalking Horse\" Asset Purchase Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-11-18 06:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 17 (Reuters) - Timber Pharmaceuticals Inc   :   * TIMBER PHARMACEUTICALS INC: PRIOR TO FILING OF CHAPTER 11 CASE, DEBTORS ENTERED INTO A \"STALKING HORSE\" ASSET PURCHASE AGREEMENT   * TIMBER ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2384395029","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2384395029","pubTimestamp":1700259865,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Nov 17  - Timber Pharmaceuticals Inc   :   * TIMBER PHARMACEUTICALS INC: PRIOR TO FILING OF CHAPTER 11 CASE, DEBTORS ENTERED INTO A \"STALKING HORSE\" ASSET PURCHASE AGREEMENT   * TIMBER PHARMACEUTICALS: AGREEMENT WAS TO SELL SUBSTANTIALLY ALL OF ASSETS OF CO, UNITS, INCLUDING TMB-001, FOR OF $14.35 MILLION PLUS CERTAIN LIABILITIES   * TIMBER PHARMACEUTICALS INC: COMPANY AND PARENT HAVE ALSO AGREED TO ENTER INTO A DEBTOR-IN-POSSESSION CREDIT FACILITYFurther company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药"},"translate_title":"简介——木材制药公司表示，在提交第11章案件之前，债务人进入了一个“跟踪马”资产购买协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMBR":1},"content_text":"Nov 17 (Reuters) - Timber Pharmaceuticals Inc   :   * TIMBER PHARMACEUTICALS INC: PRIOR TO FILING OF CHAPTER 11 CASE, DEBTORS ENTERED INTO A \"STALKING HORSE\" ASSET PURCHASE AGREEMENT   * TIMBER PHARMACEUTICALS: AGREEMENT WAS TO SELL SUBSTANTIALLY ALL OF ASSETS OF CO, UNITS, INCLUDING TMB-001, FOR OF $14.35 MILLION PLUS CERTAIN LIABILITIES   * TIMBER PHARMACEUTICALS INC: COMPANY AND PARENT HAVE ALSO AGREED TO ENTER INTO A DEBTOR-IN-POSSESSION CREDIT FACILITYFurther company coverage:    ((reuters.briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2384395029"}